A win-win solution?: A critical analysis of tiered pricing to improve access to medicines in developing countries
about
Recent developments and future prospects in the treatment of visceral leishmaniasisGlobal financing and long-term technical assistance for multidrug-resistant tuberculosis: scaling up access to treatmentStrategies for price reduction of HIV medicines under a monopoly situation in Brazil.Charting the evolution of approaches employed by the Global Alliance for Vaccines and Immunizations (GAVI) to address inequities in access to immunization: a systematic qualitative review of GAVI policies, strategies and resource allocation mechanisProjected savings through public health voluntary licences of HIV drugs negotiated by the Medicines Patent Pool (MPP).Pneumococcal conjugate vaccine implementation in middle-income countries.Compulsory Licenses for Cancer Drugs: Does Circumventing Patent Rights Improve Access to Oncology Medications?Leishmaniasis: an update of current pharmacotherapy.Minimum costs for producing hepatitis C direct-acting antivirals for use in large-scale treatment access programs in developing countries.An update on pharmacotherapy for leishmaniasisThe global challenges and opportunities in the practice of rheumatology: white paper by the World Forum on Rheumatic and Musculoskeletal Diseases.An analysis of volumes, prices and pricing trends of the pediatric antiretroviral market in developing countries from 2004 to 2012.Liposomal amphotericin B as a treatment for human leishmaniasisSynthetic biology: ensuring the greatest global value.Are good intentions putting the vaccination ecosystem at risk?Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?Can voluntary pooled procurement reduce the price of antiretroviral drugs? a case study of Efavirenz.Initiatives to challenge patent barriers and their relationship with the price of medicines procured by the Brazilian Unified National Health System.The road to elimination of hepatitis C: analysis of cures versus new infections in 91 countries.Chemotherapeutics of visceral leishmaniasis: present and future developments.Innovative Approaches to Increase Access to Medicines in Developing Countries.High sustained virological response rates using imported generic direct acting antiviral treatment for hepatitis C.Access to Medicines in Resource-limited Settings: The End of a Golden Decade?
P2860
Q26740563-52048D98-0CC9-4D3B-AB00-944CB621E16BQ28543392-DCF7360A-BDE3-44B4-9B39-3F4E9D235637Q30386525-BB6DA773-A564-43EF-933C-8AB5324A479EQ30386748-5C4A5C94-DB67-4AAB-B5E7-2328C3061A7AQ33727955-8E169922-2E3B-4091-967B-34D69EDD36D9Q33801970-F6BA383B-D11A-487F-AFFC-1AA9E6E46152Q33859745-87E24DE7-3BC8-46DA-B21F-81F8AC8D2A9DQ34318765-83EB3664-1A11-47D4-8456-97BA44D3CC44Q34396312-9DE0D2AC-D8E2-4ED7-B990-DD66CB138958Q34945204-D9978075-797F-4811-9655-A55041C5F5C5Q35533763-5AABB704-FAEF-42C9-8DE0-CCF20813E024Q35958603-0989A49E-7CE2-401E-B606-76D8AEF0C9D4Q36456032-306BE00C-B454-4878-BA32-E1922A99FB5BQ37086558-D65C1BF7-BCD3-4378-9F7A-3CB196C646E2Q37264996-DF9C41E3-686F-4389-A157-0B9874A2BDECQ38285316-1E4E5E37-5347-40D6-AC70-A629C666B07FQ39040089-890FAE41-4C1B-483A-BCAF-E71CE8E8ABACQ39124897-A5361CA1-7A3C-4337-8DC3-12A1A0C90638Q42334786-90F93C87-FE84-4BEE-9BCA-25B15A9F0A2FQ46713325-EB76A905-C4FD-473B-B16E-1229B3E5BEDFQ47152987-B107B42F-62F3-4D42-B0EC-2F16642AF81EQ47163212-0E37F876-372C-4D25-BD69-618141ECA704Q56967553-5B7FB518-80F3-4AC4-9FC5-A6D862AF3CA2
P2860
A win-win solution?: A critical analysis of tiered pricing to improve access to medicines in developing countries
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A win-win solution?: A critica ...... icines in developing countries
@ast
A win-win solution?: A critica ...... icines in developing countries
@en
type
label
A win-win solution?: A critica ...... icines in developing countries
@ast
A win-win solution?: A critica ...... icines in developing countries
@en
prefLabel
A win-win solution?: A critica ...... icines in developing countries
@ast
A win-win solution?: A critica ...... icines in developing countries
@en
P2093
P2860
P356
P1476
A win-win solution?: A critica ...... icines in developing countries
@en
P2093
Elodie Jambert
Michelle Childs
Suerie Moon
P2860
P2888
P356
10.1186/1744-8603-7-39
P577
2011-10-12T00:00:00Z